Hap Trading, LLC Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $455,629 - $804,655	-11,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $23,236 - $33,004	-400 Reduced 3.36%	11,500 $118,000
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $694,722 - $1.01 Million	11,900 New	11,900 $139,000
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $604,422 - $933,114	-18,200 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$26.12 - $43.27 $60,076 - $99,521	-2,300 Reduced 11.22%	18,200 $106,000
Q1 2020 May 08, 2020	BUY	$20.56 - $63.12 $421,480 - $1.29 Million	20,500 New	20,500 $315,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.